Detalles de la búsqueda
1.
Heme catabolism by tumor-associated macrophages controls metastasis formation.
Nat Immunol
; 22(5): 595-606, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903766
2.
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches.
J Transl Med
; 22(1): 223, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38429759
3.
Gut Microbiota, Metabolome, and Body Composition Signatures of Response to Therapy in Patients with Advanced Melanoma.
Int J Mol Sci
; 24(14)2023 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37511376
4.
Analysis of Sentinel Node Biopsy and Clinicopathologic Features as Prognostic Factors in Patients With Atypical Melanocytic Tumors.
J Natl Compr Canc Netw
; 18(10): 1327-1336, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33022642
5.
The non-small cell lung cancer immune landscape: emerging complexity, prognostic relevance and prospective significance in the context of immunotherapy.
Cancer Immunol Immunother
; 67(6): 1011-1022, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29516154
6.
Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles.
BMC Cancer
; 14: 560, 2014 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25085576
7.
Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors.
Front Immunol
; 15: 1336566, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38510242
8.
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial.
Nat Commun
; 14(1): 5914, 2023 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37739939
9.
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis.
J Immunother Cancer
; 11(6)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37286305
10.
Phase II study of sorafenib in patients with relapsed or refractory lymphoma.
Br J Haematol
; 158(1): 108-19, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22571717
11.
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy.
J Exp Clin Cancer Res
; 41(1): 325, 2022 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36397155
12.
Efficacy of mRNA anti-SARS-CoV-2 vaccination and dynamics of humoral immune response in patients with solid tumors: results from the institutional registry of an Italian tertiary cancer center.
Ther Adv Med Oncol
; 14: 17588359221108687, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35923922
13.
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.
Blood
; 113(1): 18-27, 2009 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18809757
14.
Case Report: Exceptional Response to Avelumab After Failure of Electrochemotherapy in a Patient With Rapidly Progressive, PD-L1-Negative Merkel Cell Carcinoma.
Front Oncol
; 11: 628324, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34221958
15.
Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells.
J Immunother Cancer
; 9(6)2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34127544
16.
Immune Escape Mechanisms in Non Small Cell Lung Cancer.
Cancers (Basel)
; 12(12)2020 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33276569
17.
Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma.
Cancers (Basel)
; 12(1)2020 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31906302
18.
Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram.
J Clin Oncol
; 38(14): 1591-1601, 2020 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32167862
19.
Regulation of breast cancer response to chemotherapy by fibulin-1.
Cancer Res
; 67(9): 4271-7, 2007 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17483339
20.
An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells.
Oncogene
; 38(22): 4384-4396, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30710146